New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

Cardiovascular disease (CVD) causes significant mortality and remains the leading cause of
death globally. Thus, to reduce mortality, early diagnosis by measurement of cardiac …

Type 2 diabetes is one of the most relevant risk factors for heart failure, the prevalence of
which is increasing worldwide. The aim of the review is to highlight the current perspectives …

High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin
concentrations and resolve minor changes in biomarker concentrations. Clinically, this …

The study of trimethylamine oxide (TMAO), a metabolite of gut microbiota, and heart failure
and chronic kidney disease has made preliminary achievements and been summarized by …

The risk of developing chronic illnesses and disabilities is increasing with age. To predict
and prevent aging, biomarkers relevant to the aging process must be identified. This paper …

Aims There are limited data examining whether body mass index (BMI) influences the
association between cardiovascular biomarkers and incident heart failure (HF). Methods …

Aims To evaluate the sex-specific predictive value of N-terminal pro B-type natriuretic
peptide (NT-proBNP), high sensitivity cardiac troponin T (hs-cTnT) and creatine kinase …

Panvascular disease is not only a common comorbidity of type 2 diabetes mellitus (T2DM)
but also the leading cause of disability and death in T2DM patients. To promote …

Heart failure (HF) is a clinical syndrome caused by structural and/or functional cardiac
abnormalities and resulting from impaired cardiac output or an increase of intracardiac …